GLENMEDE TRUST CO NA - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,000
-91.0%
11,558
-60.5%
0.00%
-100.0%
Q4 2020$199,000
-38.6%
29,257
+0.4%
0.00%
-50.0%
Q3 2020$324,000
+76.1%
29,135
-0.7%
0.00%
+100.0%
Q2 2020$184,000
+87.8%
29,335
+0.7%
0.00%
Q1 2020$98,0000.0%29,1350.0%0.00%
Q4 2019$98,000
+58.1%
29,1350.0%0.00%
Q3 2019$62,000
-19.5%
29,1350.0%0.00%
Q2 2019$77,000
-44.2%
29,1350.0%0.00%
-100.0%
Q1 2019$138,000
+100.0%
29,1350.0%0.00%
Q4 2018$69,000
-46.1%
29,1350.0%0.00%
-100.0%
Q3 2018$128,000
-39.0%
29,1350.0%0.00%0.0%
Q2 2018$210,000
+90.9%
29,1350.0%0.00%
Q1 2018$110,0000.0%29,1350.0%0.00%
Q4 2017$110,000
+124.5%
29,1350.0%0.00%
Q3 2017$49,000
-57.4%
29,1350.0%0.00%
-100.0%
Q2 2017$115,0000.0%29,1350.0%0.00%0.0%
Q1 2017$115,000
-19.0%
29,1350.0%0.00%0.0%
Q4 2016$142,000
-36.9%
29,1350.0%0.00%0.0%
Q3 2016$225,000
+38.0%
29,1350.0%0.00%0.0%
Q2 2016$163,000
+4.5%
29,1350.0%0.00%0.0%
Q1 2016$156,000
-38.3%
29,1350.0%0.00%
-50.0%
Q4 2015$253,000
+3.7%
29,1350.0%0.00%0.0%
Q3 2015$244,00029,1350.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders